Metastatic Prostate Cancer Diagnosed by Bone Marrow Aspiration in an Elderly Man Not Undergoing PSA Screening

Ridwan Alam; Jeffrey J. Tosoian; Ofobuike Okani; Ashley E. Ross; Milena Vuica-Ross

doi:10.1016/j.eucr.2016.12.010

Metastatic Prostate Cancer Diagnosed by Bone Marrow Aspiration in an Elderly Man Not Undergoing PSA Screening

Ridwan Alam^*, Jeffrey J. Tosoian, Ofobuike Okani, Ashley E. Ross, Milena Vuica-Ross

^*Corresponding author for this work

Urology

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Prostate cancer screening by PSA testing remains controversial, particularly in the elderly. Practice guidelines from most clinical societies suggest discontinuing PSA screening at age 70 while the USPSTF recommends against screening at any age. Recent reports have demonstrated an increased incidence of metastatic prostate cancer, with men aged 75 or older accounting for roughly half of those newly diagnosed at an incurable stage. We herein describe the case of an elderly gentleman with no history of prostate cancer screening who presented with anorexia and back pain of unclear etiology. Evaluation with bone marrow aspiration revealed a diagnosis of metastatic prostate cancer.

Original language	English (US)
Pages (from-to)	7-8
Number of pages	2
Journal	Urology Case Reports
Volume	11
DOIs	https://doi.org/10.1016/j.eucr.2016.12.010
State	Published - Feb 1 2017

Keywords

Metastasis
Older men
PSA
Prostate cancer
Screening

ASJC Scopus subject areas

Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eucr.2016.12.010

Cite this

@article{7e7e499a0f5648c6bf55f586a9cd8221,

title = "Metastatic Prostate Cancer Diagnosed by Bone Marrow Aspiration in an Elderly Man Not Undergoing PSA Screening",

abstract = "Prostate cancer screening by PSA testing remains controversial, particularly in the elderly. Practice guidelines from most clinical societies suggest discontinuing PSA screening at age 70 while the USPSTF recommends against screening at any age. Recent reports have demonstrated an increased incidence of metastatic prostate cancer, with men aged 75 or older accounting for roughly half of those newly diagnosed at an incurable stage. We herein describe the case of an elderly gentleman with no history of prostate cancer screening who presented with anorexia and back pain of unclear etiology. Evaluation with bone marrow aspiration revealed a diagnosis of metastatic prostate cancer.",

keywords = "Metastasis, Older men, PSA, Prostate cancer, Screening",

author = "Ridwan Alam and Tosoian, {Jeffrey J.} and Ofobuike Okani and Ross, {Ashley E.} and Milena Vuica-Ross",

note = "Publisher Copyright: {\textcopyright} 2016 The Authors",

year = "2017",

month = feb,

day = "1",

doi = "10.1016/j.eucr.2016.12.010",

language = "English (US)",

volume = "11",

pages = "7--8",

journal = "Urology Case Reports",

issn = "2214-4420",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Metastatic Prostate Cancer Diagnosed by Bone Marrow Aspiration in an Elderly Man Not Undergoing PSA Screening

AU - Alam, Ridwan

AU - Tosoian, Jeffrey J.

AU - Okani, Ofobuike

AU - Ross, Ashley E.

AU - Vuica-Ross, Milena

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Prostate cancer screening by PSA testing remains controversial, particularly in the elderly. Practice guidelines from most clinical societies suggest discontinuing PSA screening at age 70 while the USPSTF recommends against screening at any age. Recent reports have demonstrated an increased incidence of metastatic prostate cancer, with men aged 75 or older accounting for roughly half of those newly diagnosed at an incurable stage. We herein describe the case of an elderly gentleman with no history of prostate cancer screening who presented with anorexia and back pain of unclear etiology. Evaluation with bone marrow aspiration revealed a diagnosis of metastatic prostate cancer.

AB - Prostate cancer screening by PSA testing remains controversial, particularly in the elderly. Practice guidelines from most clinical societies suggest discontinuing PSA screening at age 70 while the USPSTF recommends against screening at any age. Recent reports have demonstrated an increased incidence of metastatic prostate cancer, with men aged 75 or older accounting for roughly half of those newly diagnosed at an incurable stage. We herein describe the case of an elderly gentleman with no history of prostate cancer screening who presented with anorexia and back pain of unclear etiology. Evaluation with bone marrow aspiration revealed a diagnosis of metastatic prostate cancer.

KW - Metastasis

KW - Older men

KW - PSA

KW - Prostate cancer

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=85008392722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85008392722&partnerID=8YFLogxK

U2 - 10.1016/j.eucr.2016.12.010

DO - 10.1016/j.eucr.2016.12.010

M3 - Article

C2 - 28083474

AN - SCOPUS:85008392722

SN - 2214-4420

VL - 11

SP - 7

EP - 8

JO - Urology Case Reports

JF - Urology Case Reports

ER -

Metastatic Prostate Cancer Diagnosed by Bone Marrow Aspiration in an Elderly Man Not Undergoing PSA Screening

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this